ArticleACS medicinal chemistry letters2015

Discovery and Development of LX7101, a Dual LIM-Kinase and ROCK Inhibitor for the Treatment of Glaucoma.

Bryce A Harrison et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.